Xiaolin Wang - EVP, Clinical Development at Revolution Medicines, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Clinical Development
Issuer Symbol
RVMD, RVMDW on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Xiaolin Wang since 11 Mar 2025

Holdings reported by Xiaolin Wang for Revolution Medicines, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 118,073 $11,332,646 $95.98 01 Mar 2026 Direct
Stock Option (Right to Buy) 34,000 01 Mar 2026 Direct Common Stock

Transactions reported by Xiaolin Wang for Revolution Medicines, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.